gastrointestinal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age 18-75 years, sex unrestricted; 2) Patients and their family members agreed and signed informed consent forms. (2) Oncology patient inclusion criteria 1) Did not receive preoperative antineoplastic therapy, samples were collected at surgery and before treatment; 2) Patients with gastrointestinal cancer who were specifically diagnosed by pathology such as histology and / or cytology; 3) No previous comorbid other malignancies;
Exclusion criteria
Exclusion criteria: 1) The patient did not sign the informed consent form or the informed consent form was not compliant; 2) Patients who had received neoadjuvant therapy preoperatively; 3) Previous history of tumors or concurrent other tumors; 4) Pregnant or lactating women; 5) Tumor recurrence; 6) Abnormal coagulation; 7) Acute upper gastrointestinal bleeding; 8) Abnormal liver and kidney function; 9) Subjects who had a blood transfusion 1 month prior to blood draw; 10) Patients who were participating in other clinical trials, or who had participated in other clinical trials with an end of follow-up of less than 1 year; 11) Patients had received any form of oncological treatment including surgery, radiotherapy / chemotherapy, endocrine therapy, targeted therapy and immunotherapy before blood draw at enrollment; 12) HBV, HIV infected patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Single cell transcriptome data;Specific chromatin open intervals; | — |
Countries
China
Contacts
The First Affiliated Hospital of PLA Air Force Military Medical University